Literature DB >> 22628553

Recurrent hemizygous deletions in cancers may optimize proliferative potential.

Nicole L Solimini1, Qikai Xu, Craig H Mermel, Anthony C Liang, Michael R Schlabach, Ji Luo, Anna E Burrows, Anthony N Anselmo, Andrea L Bredemeyer, Mamie Z Li, Rameen Beroukhim, Matthew Meyerson, Stephen J Elledge.   

Abstract

Tumors exhibit numerous recurrent hemizygous focal deletions that contain no known tumor suppressors and are poorly understood. To investigate whether these regions contribute to tumorigenesis, we searched genetically for genes with cancer-relevant properties within these hemizygous deletions. We identified STOP and GO genes, which negatively and positively regulate proliferation, respectively. STOP genes include many known tumor suppressors, whereas GO genes are enriched for essential genes. Analysis of their chromosomal distribution revealed that recurring deletions preferentially overrepresent STOP genes and underrepresent GO genes. We propose a hypothesis called the cancer gene island model, whereby gene islands encompassing high densities of STOP genes and low densities of GO genes are hemizygously deleted to maximize proliferative fitness through cumulative haploinsufficiencies. Because hundreds to thousands of genes are hemizygously deleted per tumor, this mechanism may help to drive tumorigenesis across many cancer types.

Entities:  

Mesh:

Year:  2012        PMID: 22628553      PMCID: PMC4027969          DOI: 10.1126/science.1219580

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  26 in total

Review 1.  A continuum model for tumour suppression.

Authors:  Alice H Berger; Alfred G Knudson; Pier Paolo Pandolfi
Journal:  Nature       Date:  2011-08-10       Impact factor: 49.962

2.  Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma.

Authors:  Levi A Garraway; Hans R Widlund; Mark A Rubin; Gad Getz; Aaron J Berger; Sridhar Ramaswamy; Rameen Beroukhim; Danny A Milner; Scott R Granter; Jinyan Du; Charles Lee; Stephan N Wagner; Cheng Li; Todd R Golub; David L Rimm; Matthew L Meyerson; David E Fisher; William R Sellers
Journal:  Nature       Date:  2005-07-07       Impact factor: 49.962

3.  Autosomal monoallelic expression in the mouse.

Authors:  Lillian M Zwemer; Alexander Zak; Benjamin R Thompson; Andrew Kirby; Mark J Daly; Andrew Chess; Alexander A Gimelbrant
Journal:  Genome Biol       Date:  2012-02-20       Impact factor: 13.583

4.  Akt and ERK control the proliferative response of mammary epithelial cells to the growth factors IGF-1 and EGF through the cell cycle inhibitor p57Kip2.

Authors:  Devin T Worster; Tobias Schmelzle; Nicole L Solimini; Eric S Lightcap; Bjorn Millard; Gordon B Mills; Joan S Brugge; John G Albeck
Journal:  Sci Signal       Date:  2012-03-06       Impact factor: 8.192

5.  Amplification of MDS1/EVI1 and EVI1, located in the 3q26.2 amplicon, is associated with favorable patient prognosis in ovarian cancer.

Authors:  Meera Nanjundan; Yasuhisa Nakayama; Kwai Wa Cheng; John Lahad; Jinsong Liu; Karen Lu; Wen-Lin Kuo; Karen Smith-McCune; David Fishman; Joe W Gray; Gordon B Mills
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

6.  Signatures of mutation and selection in the cancer genome.

Authors:  Graham R Bignell; Chris D Greenman; Helen Davies; Adam P Butler; Sarah Edkins; Jenny M Andrews; Gemma Buck; Lina Chen; David Beare; Calli Latimer; Sara Widaa; Jonathon Hinton; Ciara Fahey; Beiyuan Fu; Sajani Swamy; Gillian L Dalgliesh; Bin T Teh; Panos Deloukas; Fengtang Yang; Peter J Campbell; P Andrew Futreal; Michael R Stratton
Journal:  Nature       Date:  2010-02-18       Impact factor: 49.962

7.  Principles of cancer therapy: oncogene and non-oncogene addiction.

Authors:  Ji Luo; Nicole L Solimini; Stephen J Elledge
Journal:  Cell       Date:  2009-03-06       Impact factor: 41.582

Review 8.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

9.  GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer.

Authors:  Kenneth L Scott; Omar Kabbarah; Mei-Chih Liang; Elena Ivanova; Valsamo Anagnostou; Joyce Wu; Sabin Dhakal; Min Wu; Shujuan Chen; Tamar Feinberg; Joseph Huang; Abdel Saci; Hans R Widlund; David E Fisher; Yonghong Xiao; David L Rimm; Alexei Protopopov; Kwok-Kin Wong; Lynda Chin
Journal:  Nature       Date:  2009-06-25       Impact factor: 49.962

Review 10.  Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way.

Authors:  Manuela Santarosa; Alan Ashworth
Journal:  Biochim Biophys Acta       Date:  2004-06-07
View more
  113 in total

1.  Tumorigenesis. Better by half.

Authors:  Nicola McCarthy
Journal:  Nat Rev Cancer       Date:  2012-06-22       Impact factor: 60.716

2.  Collateral Lethality: A new therapeutic strategy in oncology.

Authors:  Florian L Muller; Elisa A Aquilanti; Ronald A DePinho
Journal:  Trends Cancer       Date:  2015-11-01

Review 3.  DNA Damage and Repair Biomarkers of Immunotherapy Response.

Authors:  Kent W Mouw; Michael S Goldberg; Panagiotis A Konstantinopoulos; Alan D D'Andrea
Journal:  Cancer Discov       Date:  2017-06-19       Impact factor: 39.397

Review 4.  Cellular and Molecular Mechanisms Underlying Prostate Cancer Development: Therapeutic Implications.

Authors:  Ugo Testa; Germana Castelli; Elvira Pelosi
Journal:  Medicines (Basel)       Date:  2019-07-30

5.  Characterization of a novel radiation-induced sarcoma cell line.

Authors:  Julie Lang; Weizhu Zhu; Brandon Nokes; Grishma Sheth; Petr Novak; Laura Fuchs; George Watts; Bernard Futscher; Neal Mineyev; Alexander Ring; Lauren LeBeau; Ray Nagle; Lee Cranmer
Journal:  J Surg Oncol       Date:  2015-02-02       Impact factor: 3.454

6.  Loss of LKB1 and PTEN tumor suppressor genes in the ovarian surface epithelium induces papillary serous ovarian cancer.

Authors:  Pradeep S Tanwar; Gayatry Mohapatra; Sarah Chiang; David A Engler; Lihua Zhang; Tomoko Kaneko-Tarui; Yasuyo Ohguchi; Michael J Birrer; Jose M Teixeira
Journal:  Carcinogenesis       Date:  2013-10-29       Impact factor: 4.944

7.  Detailed genome-wide SNP analysis of major salivary carcinomas localizes subtype-specific chromosome sites and oncogenes of potential clinical significance.

Authors:  Li Zhang; Yoshitsugu Mitani; Carlos Caulin; Pulivarthi H Rao; Merrill S Kies; Pierre Saintigny; Nianxiang Zhang; Randal S Weber; Scott M Lippman; Adel K El-Naggar
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

Review 8.  Cancer genome landscapes.

Authors:  Bert Vogelstein; Nickolas Papadopoulos; Victor E Velculescu; Shibin Zhou; Luis A Diaz; Kenneth W Kinzler
Journal:  Science       Date:  2013-03-29       Impact factor: 47.728

9.  The relationship of JAK2(V617F) and acquired UPD at chromosome 9p in polycythemia vera.

Authors:  L Wang; S I Swierczek; L Lanikova; S J Kim; K Hickman; K Walker; K Wang; J Drummond; H Doddapaneni; J G Reid; D M Muzny; R A Gibbs; D A Wheeler; J T Prchal
Journal:  Leukemia       Date:  2014-01-27       Impact factor: 11.528

10.  Integrative genomic characterization of oral squamous cell carcinoma identifies frequent somatic drivers.

Authors:  Curtis R Pickering; Jiexin Zhang; Suk Young Yoo; Linnea Bengtsson; Shhyam Moorthy; David M Neskey; Mei Zhao; Marcus V Ortega Alves; Kyle Chang; Jennifer Drummond; Elsa Cortez; Tong-Xin Xie; Di Zhang; Woonbok Chung; Jean-Pierre J Issa; Patrick A Zweidler-McKay; Xifeng Wu; Adel K El-Naggar; John N Weinstein; Jing Wang; Donna M Muzny; Richard A Gibbs; David A Wheeler; Jeffrey N Myers; Mitchell J Frederick
Journal:  Cancer Discov       Date:  2013-04-25       Impact factor: 39.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.